Cell culture composition containing microalgae extract and use thereof
Patent Information
- Application Number
- MYPI2025000975
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-15
- Filing Date
- 2023-11-08
- Publication Date
- 2024-06-15
AI Technical Summary
The existing fetal bovine serum (FBS) used in animal cell culture poses ethical issues, contamination problems, and supply limitations, necessitating the development of serum-free media alternatives that require additional hormones or growth factors, which complicates user convenience.
A medium composition for cell culture utilizing a microalgae extract from Thraustochytrid microalgae, which is rich in nutrients and produced through fermentation, replacing FBS to promote cell proliferation and survival without ethical or contamination concerns.
The microalgae extract-based medium composition supports cell growth and proliferation, offering a stable, cost-effective alternative to FBS, with improved productivity and reduced ethical and contamination issues, while maintaining cell viability and growth rates comparable to or exceeding those with traditional serum-containing media.
Smart Images

Figure PI2025000975_DRAWING_001 
Figure PI2025000975_DRAWING_002
Abstract
Description
Composition for cell culture containing microalgae extract and use thereof
[0001] Cross-citation with related application(s)
[0002] This application claims the benefit of priority to Korean Patent Application No. 10-2022-0175629, filed December 15, 2022, the entire contents of which are incorporated herein by reference.
[0003] The present invention relates to a cell culture composition containing a microalgae extract and its use.
[0004] Fetal bovine serum (FBS) is the most commonly used basic medium component for animal cell culture. However, ethical concerns inevitably arise during the manufacturing process of FBS, and various problems, such as contamination and limited supply, are prevalent. Therefore, the development of alternatives is essential. Various studies are underway to develop serum-free media that do not use FBS (KR 10-2021-0090560). However, these methods still require the addition of various hormones or growth factors to replace FBS, necessitating further development for user convenience.
[0005] The present invention aims to obtain an extract from biomass produced through fermentation of microalgae of the Thraustochytrid genus and utilize it as a medium component for cell culture. Unlike conventional fetal bovine serum production, the fermentation-based microalgae biomass production and extraction process offers the advantage of being free from ethical concerns and safety issues, such as contamination.
[0006] The present invention provides a medium composition for cell culture, comprising a Thraustochytrid and microalgae extract.
[0007] Another example provides a medium additive for cell culture comprising Thraustochytrid and microalgae extracts.
[0008] Another example provides a cell culture medium comprising the cell culture medium additive.
[0009] Another example provides a method of culturing cells using the above cell culture medium composition.
[0010] Another example provides the use of Thraustochytrid and microalgae extracts as media additives that can promote cell proliferation and survival while replacing animal serum.
[0011] As one aspect for achieving the above object, the present invention relates to a medium composition for cell culture comprising Thraustochytrid and microalgae extracts.
[0012] In another aspect, the present invention relates to a medium additive for cell culture, comprising a Thraustochytrid and microalgae extract.
[0013] In another aspect, the present invention relates to a medium for cell culture, comprising the medium additive.
[0014] In another aspect, the present invention relates to a method for culturing cells, comprising a step of culturing cells in the medium.
[0015] In another aspect, the present invention relates to the use of Thraustochytrid and microalgae extracts as a medium additive capable of promoting cell proliferation and survival while replacing animal serum.
[0016]
[0017] Hereinafter, the present invention will be described in more detail.
[0018] The present invention provides a medium composition for cell culture comprising Thraustochytrid and microalgae extracts.
[0019] As used herein, the term "cell culture" refers to the process of artificially growing living cells in vitro under controlled conditions. It can also involve aseptically removing a portion of a tissue from a subject, enzymatically degrading intercellular connective tissue, and spreading the resulting suspension onto the flat bottom of a culture dish, such as a bottle or petri dish, to allow the cells to grow and proliferate.
[0020] The above cell culture may include culturing cells to produce cell-cultured meat. Accordingly, the composition may be a medium composition for producing cultured meat. The medium composition of the present invention may include Thraustochytrid and microalgae extracts instead of the commonly used fetal bovine serum. The Thraustochytrid and microalgae extracts are materials rich in nutrients such as proteins and amino acids, and thus can eliminate stability issues. In addition, the production cost is lower than that of fetal bovine serum, so excellent productivity can be expected.
[0021] The term "cultured meat" in this specification refers to edible meat obtained by extracting animal cells and multiplying them using cell engineering technology, and can be said to be a field of cellular agriculture that obtains meat without going through the process of raising livestock. In Korean, it is called cultured meat, alternative meat, or artificial meat, and in English, it is called in vitro meat meaning that it is grown in a test tube, artificial meat meaning that it is synthesized using stem cells by humans rather than natural ones, clean meat meaning that it is produced in a clean production facility rather than a traditional breeding facility, and lab-grown meat because it is sometimes made in a laboratory.
[0022] The term "culture media" in this specification refers to a medium capable of supporting the growth, survival, and differentiation of cells or stem cells in vitro, and includes all conventional media suitable for the culture and differentiation of cells or stem cells used in the relevant field. Depending on the type of cell, the type of medium and culture conditions can be selected at the technical level of the relevant field. The medium used for culture is specifically a cell culture minimum medium (CCMM), which generally contains a carbon source, a nitrogen source, and trace element components. The above cell culture minimal medium may be, for example, at least one selected from the group consisting of DMEM (Dulbecco's Modified Eagle's Medium), MEM (Minimal Essential Medium), BME (Basal Medium Eagle), RPMI 1640, F-10, F-12, DMEM / F12, α-MEM (α-Minimal Essential Medium), G-MEM (Glasgow's Minimal Essential Medium), IMDM (Iscove's Modified Dulbecco's Medium), MacCoy's 5A medium, AmnioMax complete medium, AminoMax ± medium, EBM (Endothelial Basal Medium) medium, Chang's Medium, MesenCult-XF, DMEM / HG (Dulbecco's Modified Eagle's Medium high glucose) medium, and MCDB+DMEM / LG (MCDB+Dulbecco's Modified Eagle's Medium low glucose) medium. Additionally, the medium may contain an antibiotic such as penicillin, streptomycin, gentamicin, or a mixture of two or more thereof.Therefore, the cell culture medium composition of the present invention may include a microalgae extract from the Thraustochytrid family added to the cell culture minimum medium.
[0023] The term “Thraustochytrid microalgae” in this specification refers to heterotrophic microorganisms belonging to the order Thraustochytriales, which are known as oleaginous microorganisms capable of producing bio-oil containing unsaturated fatty acids such as DHA (docosahexaenoic acid), and are considered to be a good source of protein because they are rich in protein and amino acids.
[0024] The above-mentioned Thraustochytrid microalgae may be of any genus available to those skilled in the art. Specifically, it may be any one selected from the group consisting of the genera Schizochytrium, Aurantiochytrium, Thraustochytrium, and UIkenia, but is not limited thereto.
[0025] The term "extract" in this specification may refer to a result such as a liquid component obtained by immersing a target substance in various solvents and then extracting it for a certain period of time at room temperature or at a temperature, or a solid component obtained by removing the solvent from the liquid component. In addition, it may be comprehensively interpreted to include all extracts in the form of extracts themselves and extracts that can be formed using the extract, such as dilutions of the result, concentrates thereof, adjusted products thereof, purified products thereof, or mixtures thereof. In addition, the extract may include fractions obtained therefrom.
[0026] The above extract can be extracted from natural, hybrid or mutant Thraustochytrid microalgae of the Thraustochytrid family microalgae, and can also be extracted from Thraustochytrid microalgae tissue culture.
[0027] The extraction solvent of the above extract may be a protic polar solvent or an aprotic polar and non-polar solvent. The protic polar solvent may be water, methanol, ethanol, propanol, isopropanol, or butanol. The aprotic polar solvent may be dichloromethane, tetrahydrofuran, ethyl acetate, acetonitrile, dimethylformamide, dimethylsulfoxide, acetone, 2-butanone, or hexamethylphosphoramide. The non-polar solvent may be pentane, hexane, chloroform, or diethyl ether. The non-polar solvent excludes benzene. The solvent may be a C1-C6 alcohol, a C3-C10 ester, for example, a C3-C10 acetate, a C3-C10 ketone, a C1-C6 unsubstituted or halogenated hydrocarbon, a C2-C10 cyclic ether, a mixture thereof, or a mixture of one or more of the solvents with water. The solvent may be ethanol, propanol, acetonitrile, ethyl acetate, acetone, 2-butanone, chloroform, dichloromethane, hexane, a mixture thereof, or a mixture of one or more of the solvents with water. The hydrocarbon may be an alkane, an alkene, or an alkyne.
[0028] The above extract may be extracted with one or more solvents selected from the group consisting of water; C1 to C4 lower alcohols such as methanol, ethanol, propanol, and butanol; polyhydric alcohols such as glycerin, butylene glycol, and propylene glycol; and hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane. Specifically, the extract may be extracted with water as a solvent.
[0029] The above-mentioned Thraustochytrid microalgae extract may be extracted from the Thraustochytrid microalgae culture itself, or may be extracted after the culture is freeze-dried or dehydrated using a centrifuge and then subjected to other drying processes such as freeze-drying, drum drying, spray drying, or granulation using a granulator, and then manufactured into biomass, but is not limited thereto.
[0030] The term “biomass” in this specification may be, but is not limited to, microalgae of the family Traustochytridae itself, a culture thereof, a dried product thereof, a crushed product thereof, or a product produced by culturing or fermenting said microalgae, or a concentrate or dried product of said biomass.
[0031] The above Thraustochytrid family microalgae extract may be obtained by extracting Thraustochytrid family microalgae or Thraustochytrid family microalgae biomass using a conventional method, and for example, extraction methods such as hot water extraction, cold infusion extraction, reduced pressure high temperature extraction, hot water extraction, room temperature extraction, fractional extraction, reflux cooling extraction, solvent extraction, steam distillation, ultrasonic extraction, dissolution, and pressing may be used. Preferably, the extract may be obtained by using hot water extraction. In addition, if necessary, the above Thraustochytrid family microalgae extract may be a commercially available Thraustochytrid family microalgae extract.
[0032] The above hot water extraction method may be performed at 80 to 140°C, 85 to 135°C, 90 to 130°C, 95 to 125°C, 100 to 120°C, or 105 to 115°C, and in one specific example, may be performed at 110°C, but is not limited thereto. In addition, the hot water extraction method is 3 minutes or more, 5 minutes or more, 10 minutes or more, 1 to 30 minutes, 2 to 30 minutes, 3 to 30 minutes, 4 to 30 minutes, 5 to 30 minutes, 6 to 30 minutes, 7 to 30 minutes, 8 to 30 minutes, 9 to 30 minutes, 1 to 25 minutes, 2 to 25 minutes, 3 to 25 minutes, 4 to 25 minutes, 5 to 25 minutes, 6 to 25 minutes, 7 to 25 minutes, 8 to 25 minutes, 9 to 25 minutes, 1 to 20 minutes, 2 to 20 minutes, 3 to 20 minutes, 4 to 20 minutes, 5 to 20 minutes, 6 to 20 minutes, 7 to 20 minutes, 8 to 20 minutes, 9 to 20 minutes, 1 to It may be performed for 15 minutes, 2 to 15 minutes, 3 to 15 minutes, 4 to 15 minutes, 5 to 15 minutes, 6 to 15 minutes, 7 to 15 minutes, 8 to 15 minutes, or 9 to 15 minutes, and in one specific example, it may be performed for 10 minutes, but is not limited thereto.
[0033] The term "fraction" in this specification means a product obtained by performing fractionation to separate a specific component or a specific group of components from a mixture containing various components.
[0034] The fractionation method for obtaining the above fractions is not particularly limited and can be performed according to a method commonly used in the art. Non-limiting examples of the fractionation method include a fractionation method performed by treating various solvents, an ultrafiltration fractionation method performed by passing the fraction through an ultrafiltration membrane having a certain molecular weight cut-off value, a chromatographic fractionation method performed by performing various chromatographies (designed for separation according to size, charge, hydrophobicity, or affinity), and combinations thereof.
[0035] The type of fractionation solvent used to obtain the above fraction is not particularly limited, and any solvent known in the art can be used. Non-limiting examples of the fractionation solvent include polar solvents such as water and alcohols having 1 to 4 carbon atoms; non-polar solvents such as hexane, ethyl acetate, chloroform, and dichloromethane; or mixed solvents thereof. These may be used alone or in combination of one or more, but are not limited thereto.
[0036] The above-mentioned thraustochytrid microalgae extract may be included in the cell culture medium composition at a concentration of 25 g / L or less, specifically, at a concentration of 23.6 g / L or less. For example, the concentration may be 0.001 to 25 g / L, 0.005 to 25 g / L, 0.01 to 25 g / L, 0.05 to 25 g / L, 0.1 to 25 g / L, 0.2 to 25 g / L, 0.4 to 25 g / L, 0.8 to 25 g / L, 1 to 25 g / L, 2 to 25 g / L, 3 to 25 g / L, 0.001 to 23.6 g / L, 0.005 to 23.6 g / L, 0.01 to 23.6 g / L, 0.05 to 23.6 g / L, 0.1 to 23.6 g / L, 0.2 to 23.6 g / L, 0.4 to 23.6 g / L, 0.8 to 23.6 g / L, 1 to 23.6 g / L, 2 to 23.6 g / L, 3 to 23.6 g / L, 0.001 to 22 g / L, 0.005 to 22 g / L, 0.01 to 22 g / L, 0.05 to 22 g / L, 0.1 to 22 g / L, 0.2 to 22 g / L, 0.4 to 22 g / L, 0.8 to 22 g / L, 1 to 22 g / L, 2 to 22 g / L, 3 to 22 g / L, 0.001 to 20 g / L, 0.005 to 20 g / L, 0.01 to 20 g / L, 0.05 to 20 g / L, 0.1 to 20 g / L, 0.2 to 20 g / L, 0.4 to 20 g / L, 0.8 to 20 g / L, 1 to 20 g / L, 2 to 20 g / L, 3 to 20 g / L, 0.001 to 15 g / L, 0.005 to 15 g / L, 0.01 to 15 g / L, 0.05 to 15 g / L, 0.1 to 15 g / L, 0.2 to 15 g / L, 0.4 to 15 g / L, 0.8 to 15 g / L, 1 to 15 g / L, 2 to 15 g / L, 3 to 15 g / L, 0.001 to 12 g / L, 0.005 to 12 g / L, 0.01 to 12 g / L, 0.05 to 12 g / L, 0.1 to 12 g / L, 0.2 to 12 g / L, 0.4 to 12 g / L, 0.8 to 12 g / L, 1 to 12 g / L, 2 to 12 g / L, 3 to 12 g / L, 0.001 to 11 g / L, 0.005 to 11 g / L, 0.01 to 11 g / L, 0.05 to 11 g / L, 0.1 to 11 g / L, 0.2 to 11 g / L, 0.4 to 11 g / L, 0.8 to 11 g / L, 1 to 11 g / L, 2 to 11 g / L, 3 to 11 g / L, 0.001 to 10 g / L, 0.005 to 10 g / L, 0.01 to 10 g / L, 0.05 to 10 g / L, 0.1 to 10 g / L, 0.2 to 10 g / L, 0.4 to 10 g / L, 0.8 to 10 g / L, 1 to 10 g / L, 2 to 10 g / L, 3 to 10 g / L, 0.001 to 8 g / L, 0.005 to 8 g / L, 0.01 to 8 g / L, 0.05 to 8 g / L, 0.1 to 8 g / L, 0.2 to 8 g / L, 0.4 to 8 g / L, 0.8 to 8 g / L, 1 to 8 g / L, 2 to 8 g / L, 3 to 8 g / L, 0.001 to 5 g / L, 0.005 to 5 g / L, 0.01 to 5 g / L, 0.05 to 5 g / L, 0.1 to 5 g / L, 0.2 to 5 g / L, 0.4 to 5 g / L, 0.8 to 5 g / L, 1 to 5 g / L, 2 to 5 g / L, 3 to 5 g / L, 0.001 to 4 g / L, 0.005 to 4 g / L, 0.01 to 4 g / L, 0.05 to 4 g / L, 0.1 to 4 g / L, 0.2 to 4 g / L, 0.4 to 4 g / L, 0.8 to 4 g / L, 1 to 4 g / L, 2 to 4 g / L, or 3 to 4 g / L, Specifically, it can be 0.8 to 4 g / L.
[0037] The cell may be a somatic cell, an embryonic cell, a germ cell, a stem cell, a cancer cell, a cell line, a cultured cell (in vitro), a graft cell, a primary cultured cell (in vitro and ex vivo), and an in vivo cell, a cell of a eukaryotic organism or a mammalian cell including a human, for example, the cell may be selected from the group consisting of a cancer cell, a stem cell, a vascular endothelial cell, a leukocyte, an immune cell, an epithelial cell, a germ cell, a fibroblast, a muscle cell, a bone marrow cell, an epidermal cell, an osteoblast, and a neural cell. Furthermore, the eukaryotic organism may be an insect, an amphibian, a bird (chicken, turkey, duck, etc.) or a mammal (human, a primate such as a monkey, a dog, a pig, a cow, a sheep, a goat, a mouse, a rat, etc.).
[0038] The above cell may be a cell isolated from an individual or a eukaryotic organism.
[0039] The above cell may be an undifferentiated cell, a differentiated cell, or a differentiated cell, and specifically may be a stem cell.
[0040] The term "stem cell" as used herein refers to a cell having differentiation potency and self-renewal ability. Stem cells are divided into pluripotency, multipotency, and unipotency depending on their differentiation ability. The stem cell may be at least one selected from the group consisting of embryonic stem cells (ESC) (inner cells of embryos before implantation), adult stem cells (undifferentiated cells existing in each tissue and organ), and induced pluripotent stem cells (iPSC) (cells in which dedifferentiation is induced by inserting genes and / or proteins into somatic cells, or induced pluripotent stem cells).
[0041] The above stem cells are not limited in type and origin as long as they have differentiation and self-renewal capabilities. The stem cells may be derived from, for example, mammals, humans, monkeys, pigs, horses, cows, sheep, dogs, cats, mice, or rabbits. The stem cells may be derived from isolated umbilical cords, placentas, fat, bone marrow, muscles, umbilical cord blood, or amniotic fluid. The term "isolated" means existing in an environment different from the environment of naturally occurring cells or tissues. Isolating the umbilical cord, placenta, fat, bone marrow, muscles, umbilical cord blood, or amniotic fluid and obtaining stem cells therefrom may be performed by conventional anatomical methods and known methods.
[0042] The above cells may be muscle cells or muscle stem cells, and may be specifically derived from livestock such as chicken, bovine, and porcine, and more specifically may be muscle cells or muscle stem cells derived from bovine or porcine.
[0043] The term "myogenic stem cell" as used herein refers to a cell having the characteristics of a muscle stem cell, including proliferation without transformation, infinite proliferation, self-renewal ability, and the ability to differentiate into muscle. Any cell exhibiting self-renewal ability or infinite proliferation ability and muscle differentiation ability may be included without limitation. The self-renewal ability and muscle differentiation ability can be confirmed using a marker. The muscle stem cell may be used interchangeably with muscle satellite cells (SCs).
[0044] According to one embodiment, it was confirmed that a medium composition including the above thraustochytrid and microalgae extracts exhibited significantly superior cell proliferation efficacy in muscle stem cells.
[0045] The composition may further comprise serum. The serum may be at least one selected from the group consisting of fetal bovine serum (FBS), bovine calf serum (BCS), human serum, and horse serum (HS), and may be specifically fetal bovine serum.
[0046] The composition may comprise serum and a Thraustochytrid family microalgae extract, wherein the serum may be included in a weight ratio of 1000:1 to 1:1 relative to the Thraustochytrid family microalgae extract (serum: Thraustochytrid family microalgae extract). For example, the weight ratio of the serum and chlorella extract is 1000:1 to 1:1, 800:1 to 1:1, 600:1 to 1:1, 500:1 to 1:1, 400:1 to 1:1, 350:1 to 1:1, 300:1 to 1:1, 250:1 to 1:1, 200:1 to 1:1, 150:1 to 1:1, 100:1 to 1:1, 50:1 to 1:1, 40:1 to 1:1, 30:1 to 1:1, 25:1 to 1:1, 20:1 to 1:1, 15:1 to 1:1, 12.5:1 to 1:1, 10:1 to 1:1, It can be 7.5:1 to 1:1, 5:1 to 1:1, or 2.5:1 to 1:1.
[0047] The above culture composition enables cell subculture.
[0048] As used herein, the term "passage" refers to the process of continuously culturing cells, specifically stem cells, for the purpose of maintaining them in a healthy, long-term state, by replacing the culture vessel or dividing a cell population. A single replacement of the culture vessel or dividing a cell population is referred to as one passage. In the present invention, "passage" may be used interchangeably with "generation."
[0049] The above culture may be growth and proliferation. As used herein, the terms "growth and proliferation" refer to an increase in the number of cells. The above culture may be undifferentiated proliferation. Undifferentiated proliferation refers to the proliferation of stem cells into cells with the same properties as the original cells, i.e., differentiation potency and self-renewal, without differentiating into specific cells. The term "differentiation" refers to the phenomenon in which cells become specialized in structure or function during growth through division and proliferation, i.e., cells, tissues, etc. of a living organism change in shape or function to perform their respective given tasks. Measuring or determining the degree of differentiation into a specific cell type can be performed by methods well known in the art. Additionally, the differentiation can be confirmed by examining cell morphology using light microscopy or confocal microscopy, measuring changes in cell surface markers (e.g., staining cells with tissue-specific or cell-marker specific antibodies) and cell morphology (e.g., nuclear / cytoplasmic ratio) using techniques such as flow cytometry or immunocytochemistry, or by measuring changes in gene expression using techniques well known in the art such as polymerase chain reaction (PCR) and gene-expression profiling.
[0050]
[0051] In addition, the present invention provides a medium additive for cell culture, comprising a Thraustochytrid and microalgae extract.
[0052] The same parts as described above also apply to the above composition.
[0053] The above medium additive can replace all or part of the animal serum contained in the medium, and thus the cell culture medium containing the medium additive can have a reduced serum content compared to a general culture medium (containing about 10% serum). In addition, the low-serum culture medium containing the medium additive can exhibit cell growth rate, cell viability, and subculture efficiency equivalent to or significantly superior to those of a culture medium containing 10% serum.
[0054]
[0055] In addition, the present invention provides a cell culture method, including a step of culturing isolated cells using the cell culture medium composition.
[0056] The same part as explained above also applies to the above method.
[0057] The above-mentioned isolated cells may be cells isolated from livestock, and specifically, may be cells isolated from livestock such as cows, pigs, or chickens.
[0058] The above cell culture method may be a method for culturing cells for producing cultured meat, and more specifically, may be a method for proliferating and culturing muscle stem cells for producing cultured meat. Accordingly, cultured meat can be produced using cells cultured by the above method, specifically muscle stem cells.
[0059] The above culture form may be a conventional two-dimensional or three-dimensional culture known in the art. However, three-dimensional culture may be preferable to realize tissues similar to actual living tissues through cell-to-cell interactions. Specific examples of three-dimensional culture include 3D porous scaffolds, scaffold-free platforms using cells themselves or cell sheet technology, methods for arranging cells within microchips, methods using hydrogels, and methods using bioreactors.
[0060]
[0061] The present invention also provides the use of a microalgae extract from the Thraustochytrid family as a medium additive capable of promoting cell proliferation and survival while replacing animal serum.
[0062] For the purposes of the present application, the thraustochytrid microalgae, extracts, medium additives, etc. are as described above.
[0063] When culturing muscle cells in a medium containing an extract extracted from microalgae biomass belonging to the Thraustochytrid family of the present invention, it was confirmed that the cell proliferation capacity of bovine muscle cells was improved, and therefore, the cell culture composition containing the microalgae extract can be used as a substitute for fetal bovine serum among the cell culture medium components. Furthermore, since the microalgae extract included in the cell culture composition of the present invention undergoes a fermentation-based production process, unlike the existing fetal bovine serum production process, it is free from various ethical and contamination issues, and has the advantage of being able to be continuously mass-produced while maintaining a more consistent quality.
[0064]
[0065] Figure 1 is a diagram showing the cytotoxicity and cell proliferation effects of Thraustochytrid and microalgae extracts on bovine muscle stem cells. The results are expressed as the mean (N=3) ± standard deviation.
[0066] Figure 2 is a diagram showing the cell proliferation effect of culture media containing various concentrations of FBS and microalgae extracts from the Thraustochytrid family on bovine muscle stem cells. The results are expressed as the mean (N=3) ± standard deviation, and statistical comparisons were made between cells cultured in media containing the Thraustochytrid family microalgae extracts and cells cultured without the Thraustochytrid family microalgae extracts for the same culture period. (* p<0.05, ** p<0.01, *** p<0.001, Student's T-test)
[0067]
[0068] The present invention will be described in more detail below through examples. However, these examples are intended to exemplify one or more specific examples, and the scope of the present invention is not limited to these examples.
[0069]
[0070] Example 1. Obtaining microalgae extract
[0071] Schizochytrium sp. strain, belonging to the Thraustochytrid family of microalgae, was cultured in the dark and then dried to obtain biomass.
[0072] Specifically, Schizochytrium sp. strain was fermented in a 5 L fermenter containing sterilized MJW01 medium (Glucose 30 g / L, MgSO4·7H2O 3.0 g / L, Na2SO4 10 g / L, NaCl 1.0 g / L, yeast extract 9.0 g / L, MSG·1H2O 1.0 g / L, NaNO3 1.0 g / L, KH2PO4 0.1 g / L, K2HPO4 0.5 g / L, CaCl2 0.5 g / L, vitamin mixture solution 10 ml / L). The cell culture was freeze-dried as is or dehydrated using a centrifuge and then freeze-dried to obtain biomass. The obtained microalgal biomass was dispersed in purified water at a concentration of 1.5% and then heated at 110℃ for 10 minutes to perform hot water extraction. The extract was filtered to remove residual suspended matter and then freeze-dried to obtain a Thraustochytrid microalgae extract. The individual amino acid content and total amino acid content relative to the dry weight of the obtained Thraustochytrid microalgae extract were measured and are shown in Table 1 below.
[0073] Amino acid type Amino acid content (%) by dry weight Asp3.19Thr1.17Ser1.10Glu24.58Gly1.59Ala1.75Cys0.31Val1.92Met0.57Ile1.13Leu1.96Tyr0.91Phe1.25Lys1.91His0.64Arg7.45Pro0.74Total amino acids52.17
[0074] As a result, as shown in Table 1, the total amino acid content of the obtained Thraustochytrid microalgae extract relative to the dry weight was confirmed to be 52.17%, and the content of glutamic acid was the highest, followed by arginine (Arg) and aspartic acid (Asp).
[0075]
[0076] Example 2. Confirmation of cytotoxicity of microalgae extracts
[0077] To determine the effect of Thraustochytrid microalgae extracts on bovine muscle stem cells (bMuSC) extracted from sirloin and loin, the WST-8 test was performed using the following method.
[0078] Specifically, cells with passage numbers 3 or 5 were seeded at 5,000 per well in a 96-well culture plate. Three wells were seeded for each condition and cultured for 1 day at 37℃ and 5% CO2. After replacing the culture medium with fresh medium containing 10% FBS and 0.001 g / L to 40 g / L Thraustochytrid extract, the culture was cultured for 3 days, and then 5 μL of WST-8 per well was treated and cultured for an additional 3 hours. The metabolic activity of the cells was determined by measuring the optical density (OD450) at a wavelength of 450 nm using a microplate spectrophotometer. Wells containing only culture medium without cells served as blank controls, and wells not treated with Thraustochytrid extract served as negative controls. The relative cell viability was compared by comparing the OD450 values of cells treated with Thraustochytrid extract. The concentration of Thraustochytrid extract showing the highest viability was E max It was named Quest Graph TM Using the IC50 calculator, the CC that has 50% of the cell viability of the negative control 50 The values were calculated. The results of cell viability measurement according to the concentration of Thraustochytrid extract measured through this experiment are shown in Figure 1.
[0079] As a result, as shown in Fig. 1, the cell proliferation of bMuSC was similar to that of the control group when Thraustochytrid extract was included in the concentration range of 0.001 to 2 g / L. When Thraustochytrid extract was included in the concentration of 4 g / L, it increased by 115.8% compared to the control group, showing the highest cell viability within the concentration range used in the experiment, and therefore, the concentration of 4 g / L was E max It was confirmed that CC 50 The value was confirmed to be 23.6 g / L.
[0080] In conclusion, the Thraustochytrid extract did not show any toxicity to cells when included in the culture medium at a concentration of 4 g / L or less, and in particular, it was found that cell proliferation was excellent in Korean beef muscle cells (bMuSC) when the Thraustochytrid extract at the above concentration was included in the culture medium.
[0081]
[0082] Example 3. Confirmation of the serum replacement effect of Thraustochytrid extract.
[0083] To confirm the serum replacement effect of Thraustochytrid extract, the following experiment was conducted.
[0084] Specifically, E confirmed in Example 2 above under culture conditions with reduced fetal bovine serum (FBS) in the culture medium max A WST-8 assay was performed to determine the effect of adding Thraustochytrid extract at various concentrations on bMuSC cells. Small muscle cells passaged 5, 6, or 15 times were seeded in 96-well culture plates, with 5,000 cells per well, in three wells per condition. After culturing for one day at 37°C and 5% CO2, half of the culture medium was replaced with a medium containing FBS at concentrations of 0% to 10% and Thraustochytrid extract at concentrations of 0 g / L to 4 g / L. The weight ratios of the added FBS and Thraustochytrid extract are shown in Table 2 below.
[0085] FBS Concentration (%)Thraustochytrid Extract (g / L)Weight (g) per 500mL of MediaFBS:Thraustochytrid ExtractWeight RatioFBSThraustochytrid Extract0000-21-42-1050-215:1422.5:120100-2110:1425:150250-2125:14212.5:1100500-2150:14225:1
[0086]
[0087] The cells were cultured for one day to allow them to adapt to the new medium, and then replaced with new medium. WST-8 tests were performed on days 3 and 6 from the time of replacement. Cell proliferation on days 3 and 6 was determined by comparing the measured OD450 values with the OD450 values measured on day 0, and the measured results are shown in Fig. 2 and Table 3 below.
[0088] Thraustochytrid extract (g / L)Cell viability (% of D0)Day 3 (D3)Day 6 (D6)0% FBS013.810.2212.68.0424.09.01% FBS026.619.6231.240.2442.724.02% FBS032.429.2240.759.3458.266.45% FBS061.363.4258.780.2474.6110.310% FBS0100.0100.0288.5108.44104.0126.9
[0089] As a result, as shown in Fig. 2 and Table 3, it was confirmed that cell proliferation increased when bMuSC cells were cultured in a medium containing Thraustochytrid extract. Thraustochytrid extract E max When included in the concentration, the cell proliferation rate increased by 26.9% compared to the untreated control group of Thraustochytrid extract in the 10% FBS condition, 74.0% in the 5% FBS condition, and 127.4% in the 2% FBS condition based on the results of 6-day culture. In the 5% FBS condition, cell proliferation was shown to be at a level equivalent to or higher than that of the 10% FBS control group. Therefore, it can be confirmed that the Thraustochytrid extract can induce the proliferation of bMuSC cells by replacing FBS, and specifically, the Thraustochytrid extract induces the proliferation of bMuSC cells in E max When included at a concentration of 4 g / L, it can be seen that the FBS replacement rate is 50% to 80%.
Claims
1. A medium composition for cell culture comprising Thraustochytrid and microalgae extracts.
2. A cell culture medium composition according to claim 1, wherein the thraustochytrid microalgae extract is contained at a concentration of 23.6 g / L or less.
3. A cell culture medium composition according to claim 1, wherein the thraustochytrid microalgae extract is contained at a concentration of 0.4 g / L to 10 g / L or less.
4. A cell culture medium composition in the first paragraph, wherein the microalgae of the Thraustochytrid family is any one selected from the group consisting of the genera Schizochytrium, Aurantiochytrium, Thraustochytrium, and UIkenia.
5. A cell culture medium composition according to claim 1, wherein the microalgae extract of the Thraustochytrid family has a total amino acid content of 40% or more based on dry weight.
6. A cell culture medium composition according to claim 1, wherein the cells are muscle stem cells or muscle cells.
7. A cell culture medium composition according to claim 1, wherein the cells are bovine or porcine derived cells.
8. A cell culture medium composition according to claim 1, wherein the composition further comprises serum.
9. A cell culture medium composition according to claim 8, wherein the serum is at least one selected from the group consisting of fetal bovine serum (FBS), bovine calf serum (BCS), human serum, and horse serum (HS).
10. A cell culture medium composition in claim 8, wherein the serum is included in a weight ratio of 1000:1 to 1:1 (serum: thraustochytrid family microalgae extract) relative to the thraustochytrid family microalgae extract.
11. A medium additive for cell culture, comprising a traustochytrid and microalgae extract.
12. A cell culture method comprising a step of culturing isolated cells using a cell culture medium composition according to any one of claims 1 to 10.
